Skip to main content

ORIGINAL RESEARCH article

Front. Cell. Neurosci., 04 March 2019
Sec. Cellular Neuropathology
Volume 13 - 2019 | https://doi.org/10.3389/fncel.2019.00061

RETRACTED: Santacruzamate A Ameliorates AD-Like Pathology by Enhancing ER Stress Tolerance Through Regulating the Functions of KDELR and Mia40-ALR in vivo and in vitro

Retracted

A retraction of this article was approved in:

  1. Retraction: Santacruzamate A Ameliorates AD-Like Pathology by Enhancing ER Stress Tolerance Through Regulating the Functions of KDELR and Mia40-ALR in vivo and in vitro

    1. Read retraction
\r\nLei Chen&#x;Lei Chen1†Yue-cheng Liu&#x;Yue-cheng Liu2†Hui TanHui Tan1Yuan ZhangYuan Zhang1Ji XuJi Xu1Wen-lan LiuWen-lan Liu1Zong-yang Li*Zong-yang Li1*Wei-ping Li*Wei-ping Li1*
  • 1Shenzhen Key Laboratory of Neurosurgery, Brain Center, Shenzhen Second People’s Hospital, Shenzhen University 1st Affiliated Hospital, Shenzhen, China
  • 2Guangzhou Medical University, Guangzhou, China

This article has been retracted. Please follow the link to the full retraction notice for details.

Citation: Chen L, Liu Y, Tan H, Zhang Y, Xu J, Liu W, Li Z and Li W (2019) Santacruzamate A Ameliorates AD-Like Pathology by Enhancing ER Stress Tolerance Through Regulating the Functions of KDELR and Mia40-ALR in vivo and in vitro. Front. Cell. Neurosci. 13:61. doi: 10.3389/fncel.2019.00061

Received: 09 October 2018; Accepted: 06 February 2019;
Published: 04 March 2019; Retracted: 08 October 2024.

Edited by:

Stefania Ceruti, University of Milan, Italy

Reviewed by:

Ana María Sanchez-Perez, University of Jaume I, Spain
Julie Atkin, Macquarie University, Australia

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.